CY2212B1 - Stabilisation of macrolide compositions - Google Patents
Stabilisation of macrolide compositionsInfo
- Publication number
- CY2212B1 CY2212B1 CY0000068A CY0000068A CY2212B1 CY 2212 B1 CY2212 B1 CY 2212B1 CY 0000068 A CY0000068 A CY 0000068A CY 0000068 A CY0000068 A CY 0000068A CY 2212 B1 CY2212 B1 CY 2212B1
- Authority
- CY
- Cyprus
- Prior art keywords
- stabilisation
- macrolide compositions
- macrolide
- compositions
- Prior art date
Links
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9422306A GB9422306D0 (en) | 1994-11-04 | 1994-11-04 | Organic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
CY2212B1 true CY2212B1 (en) | 2002-11-08 |
Family
ID=10763919
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY0000068A CY2212B1 (en) | 1994-11-04 | 2000-12-01 | Stabilisation of macrolide compositions |
Country Status (4)
Country | Link |
---|---|
CY (1) | CY2212B1 (pl) |
GB (1) | GB9422306D0 (pl) |
PL (1) | PL184908B1 (pl) |
RU (1) | RU2181592C2 (pl) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101355422B1 (ko) * | 2005-04-13 | 2014-02-06 | 아스션 팔마 에이/에스 | 피부 결합조직질환 치료용 베타-2 아드레노리셉터 작용제 |
EP4137514A1 (en) * | 2010-10-08 | 2023-02-22 | Novartis AG | Methods of treating psoriasis using il-17 antagonists |
-
1994
- 1994-11-04 GB GB9422306A patent/GB9422306D0/en active Pending
-
1995
- 1995-10-26 PL PL95350936A patent/PL184908B1/pl unknown
- 1995-10-26 RU RU97108135A patent/RU2181592C2/ru active
-
2000
- 2000-12-01 CY CY0000068A patent/CY2212B1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
RU2181592C2 (ru) | 2002-04-27 |
GB9422306D0 (en) | 1994-12-21 |
PL184908B1 (pl) | 2003-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SI0750907T1 (en) | Stable macrolide and macrolide vaccine compositions | |
HK1011278A1 (en) | Macrolide formulations | |
GB9613043D0 (en) | Improved compositions | |
PL311736A1 (en) | Derivatives of 1h-imidazoles | |
PL313492A1 (en) | Derivative of androsterone | |
HK1023125A1 (en) | Crystalline form of 4-Ä5-methyl-3-phenylisoxazol-4-ylÜbenzenesulfonamide | |
PL341647A1 (en) | Novel derivatives of erythromycin | |
PL337606A1 (en) | Derivatives of erythromycin 9-oxime | |
PL324341A1 (en) | Pharmaceutic compositions and compounds | |
EP0788794A4 (en) | COMPOSITION FOR PREPARATION FOR EXTERNAL USE | |
PL340290A1 (en) | 2-halogeno-6-0-substituted derivatives of ketolide | |
EP0848692A4 (en) | ORGANOTON COMPOSITIONS | |
GB9508791D0 (en) | Compositions of matter | |
GB2278780B (en) | Macrolide formulations | |
GB9405229D0 (en) | Compositions of matter | |
EP0948535A4 (en) | ANTIBIOTIC COMPOSITIONS AND METHODS CONTAINING LANTHIONIN | |
CY2213B1 (en) | Stabilisation of macrolide compositions | |
GB9409944D0 (en) | New compositions of matter | |
IL121691A0 (en) | N-benzylazolium derivatives their preparation and compositions containing them | |
CY2212B1 (en) | Stabilisation of macrolide compositions | |
GB2287034B (en) | Silicone compositions | |
GB9425926D0 (en) | Silicone compositions | |
GB2327611B (en) | Macrolide compositions | |
GB9405234D0 (en) | New compositions of matter | |
GB9510222D0 (en) | Compositions of matter |